Home
ACR–ACNM–ARS–SNMMI PRACTICE PARAMETER FOR LUTETIUM-177 (Lu-177) DOTATATE THERAPY
Revised 2020 (Resolution 17)
 
PREAMBLE
 
I. INTRODUCTION
 
II. INDICATIONS
 
III. QUALIFICATIONS AND RESPONSIBILITIES OF PERSONNEL
 
IV. SPECIFICATIONS OF THE EXAMINATION AND TREATMENT
 
V. DOCUMENTATION
 
VI. STATEMENT OF THERAPEUTIC USE OF UNSEALED RADIOPHARMACEUTICAL SOURCES
 
VII. EQUIPMENT SPECIFICATIONS
 
VIII. RADIATION SAFETY
 
IX. QUALITY CONTROL AND IMPROVEMENT, SAFETY, INFECTION CONTROL, AND PATIENT EDUCATION
 
ACKNOWLEDGEMENTS
 
REFERENCES
 
Appendix A